# Vedanta Biosciences

Vedanta shifted from donor material to fully synthetic clonal consortia, commissioning a dedicated US GMP plant that produces defined-consortium drug VE303 directly from its own Master Cell Banks.

Source: https://en.bioecon.ru/companies/vedanta-biosciences/
Updated: 2026-07-01

- Country: United States

## Technologies

- [Microbiome therapeutics (live biotherapeutic products)](https://en.bioecon.ru/technology/microbiome-therapeutics-lbps/)